CSF2 and neoplasm: Recent progress in GM-CSF-based cancer immunotherapy has been reviewed, highlighting strategies such as GM-CSF monotherapy, GM-CSF-secreting cancer cell vaccines, and GM-CSF combination therapy, which contribute to the regulation of immunosuppression in the tumor microenvironment (31).